Estats Units - anglès - NLM (National Library of Medicine)

physicians total care, inc. - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin 125 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules and cephalexin for oral suspension and other antibacterial drugs, cephalexin capsules and cephalexin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cephalexin is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by s. pneumoniae and s. pyogenes (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in

Canadà - anglès - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - capsule - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canadà - anglès - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - capsule - 500mg - cephalexin (cephalexin monohydrate) 500mg - first generation cephalosporins

Canadà - anglès - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - powder for suspension - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canadà - anglès - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - powder for suspension - 125mg - cephalexin (cephalexin monohydrate) 125mg - first generation cephalosporins

Canadà - anglès - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - tablet - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canadà - anglès - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - tablet - 500mg - cephalexin (cephalexin monohydrate) 500mg - first generation cephalosporins

Canadà - anglès - Health Canada

lupin pharma canada limited - cephalexin (cephalexin monohydrate) - tablet - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canadà - anglès - Health Canada

lupin pharma canada limited - cephalexin (cephalexin monohydrate) - tablet - 500mg - cephalexin (cephalexin monohydrate) 500mg - first generation cephalosporins

Estats Units - anglès - NLM (National Library of Medicine)

stat rx usa llc - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin 125 mg in 5 ml - cephalexin for oral suspension, usp is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by streptococcus pneumoniae and streptococcus pyogenes (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin for oral suspension, usp is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.) otitis media due to streptococcus pneumoniae, haemophilus influenzae, staphylococcus aureus , streptococcus pyogenes , and moraxella catarrhalis skin and skin structure infections caused by staphylococcus aureus and/or streptococcus pyogenes bone infections caused by staphylococcus aureus and/or proteus mirabilis genitourinary tract infections